Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis

Journal of the National Cancer Institute

Volumn 110, Issue 6, 2018, Pages 560-567

  Bidard, François Clement ^a   Michiels, Stefan ^b   Riethdorf, Sabine ^c   Mueller, Volkmar ^c   Esserman, Laura J ^d   Lucci, Anthony ^e   Naume, Bjørn ^f,g   Horiguchi, Jun ^h   Gisbert Criado, Rafael ⁱ   Sleijfer, Stefan ^j   Toi, Masakazu ^k   Garcia Saenz, Jose A ^l   Hartkopf, Andreas ^m   Generali, Daniele ⁿ   Rothe, Françoise ^a,o   Smerage, Jeffrey ^r   Muinelo Romay, Laura ^q   Stebbing, Justin ^p   Viens, Patrice ^s   Magbanua, Mark Jesus M ^d   Hall, Carolyn S ^e   Engebraaten, Olav ^f,g   Takata, Daisuke ^h   Vidal Martınez, Jose ^i,t   Onstenk, Wendy ^j   Fujisawa, Noriyoshi ^k   Diaz Rubio, Eduardo ^l   Taran, Florin Andrei ^m   Cappelletti, Maria Rosa ⁿ   Ignatiadis, Michail ^o   Proudhon, Charlotte ^a   Wolf, Denise M ^d   Bauldry, Jessica B ^e   Borgen, Elin ^f   Nagaoka, Rin ^h   Carañana, Vicente ⁱ   Kraan, Jaco ^j   Maestro, Marisa ^z   Brucker, Sara Yvonne ^m   Weber, Karsten ^u   Reyal, Fabien ^z   Amara, Dominic ^d   Karhade, Mandar G ^e   Mathiesen, Randi R ^f   Tokiniwa, Hideaki ^h   Llombart Cussac, Antonio ^i,v,y   Meddis, Alessandra ^v   Blanche, Paul ^w   D'Hollander, Koenraad ^x   Pantel, Klaus ^c   more..

^a INSTITUT CURIE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h GUNMA UNIVERSITY HOSPITAL   (Japan)

ⁱ HOSPITAL ARNAU DE VILANOVA   (Spain)

^j ERASMUS MC CANCER INSTITUTE   (Netherlands)

^k KYOTO UNIVERSITY HOSPITAL   (Japan)

^l UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^m UNIVERSITY OF TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF TRIESTE   (Italy)

^o JULES BORDET INSTITUTE   (Belgium)

^p UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^q HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s AIX MARSEILLE UNIVERSITY   (France)

^t UNIVERSITÉ PARIS DESCARTES   (France)

^u GERMAN BREAST GROUP   (Germany)

^v INSERM   (France)

^w UNIVERSITÉ DE BRETAGNE SUD   (France)

^x INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^y University of Paris Cité   (France)

^z EA4629 ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CIRCULATING TUMOR CELL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; EUROPEAN; HUMAN; JAPAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); MULTICENTER STUDY; NEOADJUVANT CHEMOTHERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; TUMOR VOLUME; UNITED STATES;

EID: 85051841054     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djy018     Document Type: Article

References (20)

1. King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12(6):335-343.
2. Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis. Lancet. 2014;384(9938):164-172.
3. DeMichele A, Yee D, Berry DA, et al. The neoadjuvant model is still the future for drug development in breast cancer. Clin Cancer Res. 2015;21(13):2911-2915.
4. Comen E, Norton L, Massague J. Clinical implications of cancer self-seeding. Nat Rev Clin Oncol. 2011;8(6):369-377.
5. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897-6904.
6. Coumans FAW, Ligthart ST, Uhr JW, Terstappen LWMM. Challenges in the enumeration and phenotyping of CTC. Clin Cancer Res. 2012;18(20):5711-5718.
7. Ignatiadis M, Riethdorf S, Bidard FC, et al. International study on inter-reader variability for circulating tumor cells in breast cancer. Breast Cancer Res. 2014; 16(2):R43.
8. Bidard FC, Peeters DJ, Fehm T, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data. Lancet Oncol. 2014;15(4):406-414.
9. Lorente D, Olmos D, Mateo J, et al. Decline in circulating tumor cell count and treatment outcome in advanced prostate cancer. Eur Urol. 2016;70(6):985-992.
10. Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011;29(12):1556-1563.
11. Morrow CJ, Trapani F, Metcalf RL, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: A clinical case study. Ann Oncol. 2016;27(6):1155-1160.
12. Baccelli I, Schneeweiss A, Riethdorf S, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539-544.
13. Cayrefourcq L, Mazard T, Joosse S, et al. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res. 2015;75(5): 892-901.
14. Michiels S, Baujat B, Mahe C, et al. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses. J Clin Epidemiol. 2005;58(3):238-245.
15. Tudur Smith C, Williamson PR. A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes. Clin Trials. 2007;4(6):621-630.
16. Bidard FC, Kirova YM, Vincent-Salomon A, et al. Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer. Ann Oncol. 2009;20(11):1836-1841.
17. Andree KC, van Dalum G, Terstappen LWMM. Challenges in circulating tumor cell detection by the CellSearch system. Mol Oncol. 2016;10(3):395-407.
18. Bidard FC, Proudhon C, Pierga JY. Circulating tumor cells in breast cancer. Mol Oncol. 2016;10(3):418-430.
19. Alix-Panabières C, Mader S, Pantel K. Epithelial-mesenchymal plasticity in circulating tumor cells. J Mol Med. 2017;95(2):133-142.
20. Cabel L, Proudhon C, Gortais H, et al. Circulating tumor cells: clinical validity and utility. Int J Clin Oncol. 2017;22(3):421-430.